Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) Stock Gains On Approval of Reverse Stock Split
The biotech sector has attracted a lot of attention from investors over the course of the past years and remains one of the more sought-after sectors. One of the biotech stocks which came into focus in a big way among investors on Thursday was of the clinical-stage biotech firm Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT). Trading Data On Thursday, PVCT stock surged 15% to $0.0609 with more than 280K shares, compared to…